BioCentury
ARTICLE | Clinical News

MVA3000: Phase II start

May 2, 2005 7:00 AM UTC

The partners will begin this quarter a U.S. Phase II trial in healthy volunteers. The smallpox vaccine has Fast Track designation in the U.S. ...